0001883850-23-000023.txt : 20230105 0001883850-23-000023.hdr.sgml : 20230105 20230105163726 ACCESSION NUMBER: 0001883850-23-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RYAN ARTHUR F CENTRAL INDEX KEY: 0001187443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 23511990 MAIL ADDRESS: STREET 1: CITIZENS FINANCIAL GROUP, INC STREET 2: 600 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2023-01-03 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001187443 RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2023-01-03 4 S 0 14 721.48 D 19268 D Common Stock 2023-01-03 4 S 0 5 722.59 D 19263 D Common Stock 2023-01-03 4 S 0 10 723.52 D 19253 D Common Stock 2023-01-03 4 S 0 9 724.52 D 19244 D Common Stock 2023-01-03 4 S 0 9 725.63 D 19235 D Common Stock 2023-01-03 4 S 0 10 726.34 D 19225 D Common Stock 2023-01-03 4 S 0 13 727.59 D 19212 D Common Stock 2023-01-03 4 S 0 11 728.34 D 19201 D Common Stock 2023-01-03 4 S 0 1 729.92 D 19200 D Common Stock 2023-01-03 4 S 0 4 730.35 D 19196 D Common Stock 2023-01-03 4 S 0 12 731.59 D 19184 D Common Stock 2023-01-03 4 S 0 2 732.18 D 19182 D Common Stock 2023-01-03 4 A 0 165 0.0 A 19347 D Non-Qualified Stock Option (right to buy) 725.89 2023-01-03 4 A 0 1929 0.0 A 2033-01-03 Common Stock 1929 1929 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 14 shares of Company stock on January 3, 2023 at prices ranging from $721.09 to $721.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 5 shares of Company stock on January 3, 2023 at prices ranging from $722.01 to $722.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $723.25 to $723.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $724.05 to $724.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $725.00 to $725.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $726.00 to $726.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 13 shares of Company stock on January 3, 2023 at prices ranging from $727.06 to $727.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 11 shares of Company stock on January 3, 2023 at prices ranging from $728.02 to $728.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 4 shares of Company stock on January 3, 2023 at prices ranging from $730.17 to $730.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 12 shares of Company stock on January 3, 2023 at prices ranging from $731.03 to $731.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Represents volume-weighted average price of sales of 2 shares of Company stock on January 3, 2023 at prices ranging from $732.00 to $732.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price. Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock. On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. /s/**Arthur F. Ryan 2023-01-05